血清多氨酸与心血管事件和慢性病全因死亡率的关联
Zijin Chen1,2, Shaobo Wang1, Li Liu1
1Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Kidney Diseases of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Cardiorenal medicine
|March 4, 2025
概括
血清多氨酸 (素,精氨酸,精氨酸) 在慢性病 (CKD) 中发生变化,并预测心血管事件和死亡风险. 这些多胺可以作为CKD患者有价值的预后指标.
科学领域:
- 生物化学 生物化学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
背景情况:
- 血清多氨酸 (普特雷辛,精子胺,精子胺) 正在成为慢性病 (CKD) 的潜在生物标志物.
- 血清聚胺水平与心血管 (CV) 事件或CKD患者的死亡率之间的关联尚不清楚.
研究的目的:
- 研究血清聚胺水平与心血管疾病 (CVD) 风险和CKD患者的整体死亡率之间的关系.
- 探索血清聚胺在CKD进展中的预后价值.
主要方法:
- 对297名成年CKD患者 (1-5阶段) 的回顾性队列研究.
- 使用高性能液态染色学量化血清聚胺水平,并以四分位数进行分析.
- 使用卡普兰-梅尔曲线,单变量/多变量考克斯回归和竞争风险分析来评估与心血管事件和死亡率的关联.
主要成果:
- 血清聚胺水平与估计的淋巴细胞过率 (eGFR) 相相关:普特雷辛呈阴性,精子素和精子素呈阳性.
- 较高的布特雷斯水平与心血管事件的风险显著增加有关 (HR 6.972).
- 较高的精氨酸 (HR 0.077) 和精氨酸 (HR 0.180) 水平与心血管事件和整体死亡率的风险降低有关,在竞争风险模型中强大.
结论:
- 在CKD患者中,血清聚胺水平显著受到干扰,与EGFR相关.
- 血清聚胺水平的变化与心血管事件和整体死亡率的风险增加有关.
- 血清多氨酸显示出作为CKD患者有价值的预后指标的潜力.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
41
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
01:17Factors Affecting Renal Clearance: Renal Impairment
47
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
47
01:22Heart Failure Drugs: Diuretics
324
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
324
01:10Nephrons
2.0K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363